Terry Lichtor to Interleukin-2
This is a "connection" page, showing publications Terry Lichtor has written about Interleukin-2.
Connection Strength
0.813
-
Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts. J Neurosurg. 2007 Feb; 106(2):299-305.
Score: 0.298
-
Cytokine immuno-gene therapy for treatment of brain tumors. J Neurooncol. 2003 Dec; 65(3):247-59.
Score: 0.239
-
Enhanced immunity to intracerebral breast cancer in mice immunized with a cDNA-based vaccine enriched for immunotherapeutic cells. J Immunother. 2008 Jan; 31(1):18-27.
Score: 0.079
-
Immunogene therapy as a treatment for malignant brain tumors in young mice. J Neurosurg. 2006 Jul; 105(1 Suppl):65-70.
Score: 0.071
-
Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer. Cancer Gene Ther. 2005 Aug; 12(8):708-14.
Score: 0.067
-
Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors. J Neurooncol. 2003 Aug-Sep; 64(1-2):139-46.
Score: 0.058